JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1988) 118, 271-277       DOI: 10.1677/joe.0.1180271
© 1988 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rijnberk, A.
Right arrow Articles by Croughs, R. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rijnberk, A.
Right arrow Articles by Croughs, R. J. M.

Effects of bromocriptine on corticotrophin, melanotrophin and corticosteroid secretion in dogs with pituitary-dependent hyperadrenocorticism

A. Rijnberk, J. A. Mol, M. M. Kwant and R. J. M. Croughs

Dogs with spontaneous pituitary-dependent hyperadrenocorticism were divided into two groups, one with normal plasma concentrations of {alpha}-MSH (normal {alpha}-MSH dogs, n = 26) and the other with high plasma concentrations of {alpha}-MSH (high {alpha}-MSH dogs, n= 14), on the presumption that high {alpha}-MSH concentrations indicated a parent cell of pars intermedia origin.

The urinary corticoid/creatinine ratios of the high {alpha}-MSH dogs were significantly higher than those of the normal {alpha}-MSH dogs. The percentage decrease of the corticoid/creatinine ratios following dexamethasone administration was significantly higher in the normal {alpha}-MSH dogs than in the high {alpha}-MSH dogs. Dexamethasone resistance occurred in both the normal {alpha}-MSH dogs (4 out of 26) and the high {alpha}-MSH dogs (7 out of 14), indicating a relative rather than an absolute difference.

The short-term effect of orally administered bromocriptine, at a dose (10 µg/kg body weight) known to be effective in lowering prolactin concentrations in dogs, was investigated by measuring concentrations of cortisol, ACTH and {alpha}-MSH in plasma at 4, 6 and 8 h after administration. Significant decreases were observed for cortisol in both groups and for {alpha}-MSH only in the high {alpha}-MSH dogs.

The effect of 5 days of bromocriptine administration (10 µg at 12-h intervals) was assessed by measurements of urinary corticoid/creatinine ratios. Considering both groups as a whole, only the corticoid/creatinine ratios of the high {alpha}-MSH dogs decreased significantly on the first day of treatment. In each group there was one dog in which bromocriptine administration lowered the corticoid/creatinine ratios for several days, but the values stayed above the reference range and the animals did not recover.

It is concluded that high {alpha}-MSH concentrations are not unambiguously associated with the theoretically expected characteristics of pars intermedia disease. The results indicate that the pituitary lesions causing hyperadrenocorticism may not maintain the regulation characteristics of the lobe of origin.

J. Endocr. (1988) 118, 271–277




This article has been cited by other articles:


Home page
J EndocrinolHome page
J M Hanson, H S Kooistra, J A Mol, E Teske, and B P Meij
Plasma profiles of adrenocorticotropic hormone, cortisol, {alpha}-melanocyte-stimulating hormone, and growth hormone in dogs with pituitary-dependent hyperadrenocorticism before and after hypophysectomy.
J. Endocrinol., September 1, 2006; 190(3): 601 - 609.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the Society for Endocrinology.